Original Articles: Antiasthma Drugs: Key Issues in Clinical Trial Methodology

References

• Juniper E F, Frith P A, Hargreave F E. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981; 36: 575–579
   PubMed Web of Science ®Google Scholar
• Barnes P J. The drug therapy of asthma: directions for the 21st century. Agents Actions 1988; 23: 293–313, (suppl)
   PubMedGoogle Scholar
• Barnes P J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989; 83(6)1013–1026
   PubMed Web of Science ®Google Scholar
• Woolcock A J, Yan K, Salome L M. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy 1988; 18: 165–176
   PubMedGoogle Scholar
• British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: I—chronic persistent asthma. Br Med J 1990; 301: 651–654
   PubMedGoogle Scholar
• British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: II—acute severe asthma. Br Med J 1990; 301: 800–802
   PubMedGoogle Scholar
• Cockcroft D W. Modulation of airway hyperresponsiveness. Ann Allergy 1988; 60: 465–471
   PubMedGoogle Scholar
• Juniper E F, Kline P A, Vanzieleghem M A, Hargreave F E. Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991; 87(2)483–489
   PubMed Web of Science ®Google Scholar
• Beasley R, Roche W R, Roberts J A, Holgate S T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806–817
   PubMed Web of Science ®Google Scholar
• Chervinsky P, Bronsky E, Dockhorn R, et al. Fluticasone propionate (FP) aerosol in asthma. J Allergy Clin Immunol 1991; 87(1)255
   Google Scholar
• Neville E, Corris P A, Vivian J, et al. Nebulized salbutamol and angina. Br Med J 1982; 285: 796
   PubMedGoogle Scholar
• Chapman K R, Smith D L, Rebuck A S, et al. Hemodynamic effects of an inhaled beta-2 agonist. Clin Pharmacol Ther 1984; 35: 762
   PubMedGoogle Scholar
• Josephson G W, Kennedy H L, Mackenzie E J, Gibson G. Cardiac dysrhythmias during the treatment of acute asthma. Chest 1980; 78: 429–435
   PubMedGoogle Scholar
• Levine J H, Michael J R, Guarnieri T. Multifocal atrial tachycardia: a toxic effect of theophylline. Lancet 1985; 1: 12–14
   PubMedGoogle Scholar
• Kemp J P, Chervinsky P, Orgel H A, et al. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy with 24 hour electro-cardiographic monitoring. J Allergy Clin Immunol 1984; 73: 32–43
   PubMed Web of Science ®Google Scholar
• Shorter C B, Polnitsky C A. The relationship of viral infections to subsequent asthma. Clin Chest Med 1981; 2: 67–78
   PubMedGoogle Scholar
• Halperin S A, Eggleston P A, Beasley P, et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132: 976–980
   PubMed Web of Science ®Google Scholar
• Cockcroft D W. Nonallergic airway responsiveness. J Allergy Clin Immunol 1988; 81: 111–119
   PubMedGoogle Scholar
• Pierson W E, LaForce C F, Bell T D, MacCosbe P E, Sykes R S, Tinkelman D. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol 1990; 85: 618–626
   PubMedGoogle Scholar
• Jackson R H, McHenry J I, Moreland F B, Raymer W J, Etter R L. Clinical evaluation of elixophylline with correlation of pulmonary function studies and theophylline serum levels in acute and chronic asthmatic patients. Dis Chest 1964; 45: 75–85
   PubMedGoogle Scholar
• Jenne J W, Wyze E, Rood F S, McDonald F M. Pharmacokinetics of theophylline: Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 1972; 13: 349–360
   PubMed Web of Science ®Google Scholar
• Nicholson D P, Chick T W. A re-evaluation of parenteral aminophylline. Am Rev Respir Dis 1973; 108: 241–247
   PubMedGoogle Scholar
• Turner-Warwick M. Study of theophylline plasma levels after oral administration of new theophylline compounds. Br Med J 1957; 2: 67–69
   PubMed Web of Science ®Google Scholar
• Hendeles L, Weinberger M, Bighley L. Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis 1978; 118: 97–103
   PubMed Web of Science ®Google Scholar
• Jacobs M H, Senior R M, Kessler G. Clinical experience with theophylline: relationships between dosage, serum concentration and toxicity. JAMA 1976; 235: 1983–1986
   PubMed Web of Science ®Google Scholar
• Zwillich C W, Sutton F D, Neff T A, Cohn W M, Matthay R A, Weinberger M M. Theophylline-induced seizures in adults: correlation with serum concentrations. Ann Intern Med 1975; 82: 784–787
   PubMed Web of Science ®Google Scholar
• Helliwell M, Berry D. Theophylline poisoning in adults. Br Med J 1979; 2: 1114
   PubMed Web of Science ®Google Scholar
• Culberson C G, Langston J W, Herrick M. Aminophylline encephalopathy: a clinical electro-encephalographic and neuropathological analysis. Trans Am Neurol Assoc 1979; 104: 224–226
   PubMedGoogle Scholar
• Hendeles L, Bighley L, Richardson R H, Hepler C D, Carmichael J. Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 1977; 11: 12–18
   Google Scholar
• Hargreave F E, Ryan G, Thomson N C, O'Byrne P M, Latimer K, Juniper E F, Dolovich J. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981; 68(5)347–355
   PubMed Web of Science ®Google Scholar
• Ryan G, Dolovich M B, Roberts R S, Frith P A, Juniper E F, Hargreave F E, Newhouse M T. Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis 1981; 123: 195–199
   PubMed Web of Science ®Google Scholar
• Murray A B, Ferguson A C, Morrison B. Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981; 68(2)119–124
   PubMed Web of Science ®Google Scholar
• Bandourakis J, Cartier A, Roberts B, Ryan G, Hargreave P E. The effect of ipratropium and fenoterol on methacholine- and histamine-induced bronchoconstriction. Br J Dis Chest 1981; 75: 295
   PubMedGoogle Scholar
• Grubb R E, Hopp R, Dave N K, Brennan B, Bewtra A, Townley R. Effect of inhaled furosemide on the bronchial response to methacholine and cold-air hyperventilation challenges. J Allergy Clin Immunol 1990; 85: 881–884
   PubMedGoogle Scholar
• Magnussen H, Reuss G, Jorres R, Aurich R. Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction. J Allergy Clin Immunol 1989; 83: 467–471
   PubMed Web of Science ®Google Scholar
• Wardlaw A J, Hay H, Cromwell O, Collins J V, Kay A B. Leukotrienes, LTC4 and LTB4 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989; 84: 19–26
   PubMed Web of Science ®Google Scholar
• Bernstein I L. Bronchoalveolar lavage in asthma-“Something old something new …”. J Allergy Clin Immunol 1984; 74(l)22–25
   PubMedGoogle Scholar
• Hunninghake G W, Gadek J E, Kawanami O, et al. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979; 97: 149
   PubMed Web of Science ®Google Scholar
• Thompson A B, Mueller M, Heires A, Bohling T, Daughton D, Ertl R, Yancey S, Sykes R S, Rennard S. Improved pulmonary function and diminished airways inflammation in patients on inhaled beclo-methasone. Am Rev Respir Dis 1990; 141(4)A321
   PubMedGoogle Scholar
• Burrows B, Martinez F D, Halonen M, Barbee R, Cline M G. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320: 271–277
   PubMed Web of Science ®Google Scholar
• Van Arsdel P P, Jr, Larson E B. Diagnostic tests for patients with suspected allergic disease. Ann Int Med 1989; 110(4)304–312
   PubMedGoogle Scholar
• Spector S L, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trials. J Allergy Clin Immunol 1986; 77: 65–70
   PubMed Web of Science ®Google Scholar
• Sly R M. Mortality from asthma. J Allergy Clin Immunol 1989; 84(4)421–434
   PubMedGoogle Scholar
• Benatar S R. Fatal Asthma. N Engl J Med 1986; 314(7)423–429
   PubMed Web of Science ®Google Scholar
• Nicklas R A. Perspective on asthma mortality -1989. Ann Allergy 1989; 63: 578–584
   PubMedGoogle Scholar
• Robin E D. Death from bronchial asthma. Chest 1988; 93: 614–618
   PubMed Web of Science ®Google Scholar
• Nicklas R A. Paradoxical bronchospasm associated with the use of inhaled beta agonists. J Allergy Clin Immunol 1990; 85(5)959–964
   PubMedGoogle Scholar
• Cocchetto D M, Sykes R S, Spector S. Paradoxical bronchospasm after use of inhalation aerosols: A review of the literature. J Asthma 1991; 28(l)49–53
   PubMedGoogle Scholar
• Cross D, Nelson H S. The role of the peak flow meter in the diagnosis and management of asthma. J Allergy Clin Immunol 1991; 87(l)120–128
   PubMedGoogle Scholar